Aspartate Aminotransferase (AST)
Females, Age 30-39
The median aspartate aminotransferase (AST) for US females aged 30-39 is 16 U/L, with 90% of the population falling between 12 U/L and 35.6 U/L.
NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 676 participants · Unit: U/L
Percentile Distribution
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (U/L) | 12 | 13 | 14 | 16 | 19 | 25 | 35.6 |
| 95% CI | 11 | 12 | 14 | 16 | 19 | 22 | 29 |
| Percentile | Value (U/L) | 95% CI |
|---|---|---|
| P5 | 12 | 11 |
| P10 | 13 | 12 |
| P25 | 14 | 14 |
| P50 | 16 | 16 |
| P75 | 19 | 19 |
| P90 | 25 | 22 |
| P95 | 35.6 | 29 |
The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.
14 16 19
P25 P50 P75
P5 12 P95 35.6
Data and Methodology
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from full MEC sample)
- Survey years
- 2017-2020
- Measurement
- Measured by kinetic enzymatic assay (modified IFCC method) on Roche Cobas 6000 (c501 module). How it was measured
- Sample size
- 676 participants
- Reference population
- US civilian non-institutionalized females aged 30-39 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing AST measurement (LBXSASSI)
- Missing or zero MEC sample weight (WTMEC)
- Age outside 30-39 range
- Notes
- Percentiles computed using the combined pre-pandemic MEC weight (WTMECPRP). AST measured as LBXSASSI in U/L.